FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999011621> ?p ?o ?g. }

• W2999011621 abstract "Melanoma is the most aggressive type of skin cancer with high mortality rate and poor prognosis. lncRNA MEG3, a tumor suppressor, is closely related to the development of various cancers. However, the role of lncRNA MEG3 in melanoma has seldom been studied.RT-PCR was used to examine the expressions of lncRNA MEG3 and E-cadherin in melanoma patients and cell lines. Then, the biological functions of lncRNA MEG3 and E-cadherin were demonstrated by transfecting lncRNA MEG3-siRNA, lncRNA MEG3-overexpression, E-cadherin-siRNA and E-cadherin-overexpression plasmids in melanoma cell lines. Moreover, CCK8 assay and colony formation assay were utilized to assess the cell proliferation; Transwell assay was performed to evaluate the cell invasive ability; and tumor xenografts in nude mice were applied to test the tumor generation. Additionally, the target interactions among lncRNA MEG3, miR-21 and E-cadherin were determined by dual luciferase reporter assay. Finally, RT-PCR and WB were further conducted to verify the regulatory roles among lncRNA MEG3, miR-21 and E-cadherin.The clinical data showed that lncRNA MEG3 and E-cadherin expressions were both declined in carcinoma tissues as compared with their para-carcinoma tissues. Moreover, lncRNA MEG3 and E-cadherin expressions in B16 cells were also higher than those in A375 and A2058 cells. Subsequently, based on the differently expressed lncRNA MEG3 and E-cadherin in these human melanoma cell lines, we chose B16, A375 and A2058 cells for the following experiments. The results demonstrated that lncRNA MEG3 could suppress the tumor growth, tumor metastasis and formation; and meanwhile E-cadherin had the same effects on tumor growth, tumor metastasis and formation. Furthermore, the analysis of Kaplan-Meier curves also confirmed that there was a positive correlation between lncRNA MEG3 and E-cadherin. Ultimately, dual luciferase assays were further used to verify that lncRNA MEG3 could directly target miR-21 which could directly target E-cadherin in turn. Additionally, the data of RT-PCR and WB revealed that knockdown of lncRNA MEG3 in B16 cells inhibited miR-21 expression and promoted E-cadherin expression, but overexpression of lncRNA MEG3 in A375 and A2058 cells presented completely opposite results.Our findings indicated that lncRNA MEG3 might inhibit the tumor growth, tumor metastasis and formation of melanoma by modulating miR-21/E-cadherin axis." @default.
• W2999011621 created "2020-01-23" @default.
• W2999011621 creator A5018596419 @default.
• W2999011621 creator A5041861234 @default.
• W2999011621 creator A5064351041 @default.
• W2999011621 creator A5064501760 @default.
• W2999011621 creator A5068628208 @default.
• W2999011621 creator A5084258079 @default.
• W2999011621 date "2020-01-10" @default.
• W2999011621 modified "2023-10-17" @default.
• W2999011621 title "LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis" @default.
• W2999011621 cites W1483708050 @default.
• W2999011621 cites W1575391989 @default.
• W2999011621 cites W1881660869 @default.
• W2999011621 cites W1964498732 @default.
• W2999011621 cites W1974852835 @default.
• W2999011621 cites W2026986677 @default.
• W2999011621 cites W2054233335 @default.
• W2999011621 cites W2075543245 @default.
• W2999011621 cites W2099176640 @default.
• W2999011621 cites W2139707421 @default.
• W2999011621 cites W2162547088 @default.
• W2999011621 cites W2222749547 @default.
• W2999011621 cites W2300492004 @default.
• W2999011621 cites W2544311982 @default.
• W2999011621 cites W2578530714 @default.
• W2999011621 cites W2606262935 @default.
• W2999011621 cites W2607123116 @default.
• W2999011621 cites W2625600561 @default.
• W2999011621 cites W2738175936 @default.
• W2999011621 cites W2792555078 @default.
• W2999011621 cites W2794835809 @default.
• W2999011621 cites W2796298526 @default.
• W2999011621 cites W2885375728 @default.
• W2999011621 cites W2897119059 @default.
• W2999011621 cites W2904953089 @default.
• W2999011621 cites W2905078940 @default.
• W2999011621 cites W2905124962 @default.
• W2999011621 cites W2912541104 @default.
• W2999011621 cites W2915083816 @default.
• W2999011621 cites W2916175286 @default.
• W2999011621 cites W2917349269 @default.
• W2999011621 cites W3024310080 @default.
• W2999011621 cites W4211020617 @default.
• W2999011621 cites W4298209683 @default.
• W2999011621 doi "https://doi.org/10.1186/s12935-019-1087-4" @default.
• W2999011621 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6954595" @default.
• W2999011621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31938020" @default.
• W2999011621 hasPublicationYear "2020" @default.
• W2999011621 type Work @default.
• W2999011621 sameAs 2999011621 @default.
• W2999011621 citedByCount "39" @default.
• W2999011621 countsByYear W29990116212020 @default.
• W2999011621 countsByYear W29990116212021 @default.
• W2999011621 countsByYear W29990116212022 @default.
• W2999011621 countsByYear W29990116212023 @default.
• W2999011621 crossrefType "journal-article" @default.
• W2999011621 hasAuthorship W2999011621A5018596419 @default.
• W2999011621 hasAuthorship W2999011621A5041861234 @default.
• W2999011621 hasAuthorship W2999011621A5064351041 @default.
• W2999011621 hasAuthorship W2999011621A5064501760 @default.
• W2999011621 hasAuthorship W2999011621A5068628208 @default.
• W2999011621 hasAuthorship W2999011621A5084258079 @default.
• W2999011621 hasBestOaLocation W29990116211 @default.
• W2999011621 hasConcept C104317684 @default.
• W2999011621 hasConcept C121608353 @default.
• W2999011621 hasConcept C126322002 @default.
• W2999011621 hasConcept C127561419 @default.
• W2999011621 hasConcept C1491633281 @default.
• W2999011621 hasConcept C149402561 @default.
• W2999011621 hasConcept C2777658100 @default.
• W2999011621 hasConcept C2779013556 @default.
• W2999011621 hasConcept C2781369401 @default.
• W2999011621 hasConcept C502942594 @default.
• W2999011621 hasConcept C54355233 @default.
• W2999011621 hasConcept C62112901 @default.
• W2999011621 hasConcept C62203573 @default.
• W2999011621 hasConcept C71924100 @default.
• W2999011621 hasConcept C81885089 @default.
• W2999011621 hasConcept C86803240 @default.
• W2999011621 hasConceptScore W2999011621C104317684 @default.
• W2999011621 hasConceptScore W2999011621C121608353 @default.
• W2999011621 hasConceptScore W2999011621C126322002 @default.
• W2999011621 hasConceptScore W2999011621C127561419 @default.
• W2999011621 hasConceptScore W2999011621C1491633281 @default.
• W2999011621 hasConceptScore W2999011621C149402561 @default.
• W2999011621 hasConceptScore W2999011621C2777658100 @default.
• W2999011621 hasConceptScore W2999011621C2779013556 @default.
• W2999011621 hasConceptScore W2999011621C2781369401 @default.
• W2999011621 hasConceptScore W2999011621C502942594 @default.
• W2999011621 hasConceptScore W2999011621C54355233 @default.
• W2999011621 hasConceptScore W2999011621C62112901 @default.
• W2999011621 hasConceptScore W2999011621C62203573 @default.
• W2999011621 hasConceptScore W2999011621C71924100 @default.
• W2999011621 hasConceptScore W2999011621C81885089 @default.
• W2999011621 hasConceptScore W2999011621C86803240 @default.
• W2999011621 hasFunder F4320335795 @default.
• W2999011621 hasIssue "1" @default.
• W2999011621 hasLocation W29990116211 @default.
• W2999011621 hasLocation W29990116212 @default.

• next